David Tuller (University of California, Berkeley), Steven Lubet (Northwestern University), and I have written an opinion piece over at Health Affairs. It’s on the implications of recent developments in ME and chronic fatigue syndrome for the treatment of Long COVID. We argue that the paradigm shift signalled by the UK’s […]
Last October, I wrote that COVID-19 had created a stampede of shoddy research. Little has changed in the interim. Putting all hands to the pump might feel appropriate in a crisis, but during a global public health emergency, rushing headlong into the scholarly frontline is anything but okay. Frankly, it is […]
I am a bit late posting this, but there you go. Watchyagonnadoaboutit. The other week I was quoted in the Irish Times on the matter of risk perception and vaccines: Proper risk assessments should combine two factors: impact and probability. In other words: “how bad something is” and “how likely […]
Steven Lubet, a law professor at Northwestern University, has written a powerful piece over at Social Science Space, responding to the awful Op-Ed on Long COVID that appeared the other week in the Wall Street Journal. He doesn’t hold back: It would be mistaken to suppose that disdain for patients […]
Swiss Re Group, “one of the world’s leading providers of reinsurance and insurance,” recently hosted a virtual Expert Forum on “secondary” impacts of COVID. As would be expected, the insurance industry is especially interested in the financial implications of this new disease. The programme covered many of the biophysical sequelae […]
Here I am on the latest PSI Podcast, with Professor Luke O’Neill and host Breda Brown. Do have a listen… * * *
